expression vectors nlrp3 expression vectors pegfp c2 nlrp3 Search Results


93
Addgene inc human pegfp c2 nlrp3 plasmid
Human Pegfp C2 Nlrp3 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm34217831-64-0-12?v=Addgene+inc
Average 93 stars, based on 1 article reviews
human pegfp c2 nlrp3 plasmid - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

99
Sino Biological nlrp3
Nlrp3, supplied by Sino Biological, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/custom%40nlrp3%4031849970?v=Sino+Biological
Average 99 stars, based on 1 article reviews
nlrp3 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

92
Addgene inc pcdna myc nlrp3 r260w
Pcdna Myc Nlrp3 R260w, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/bio_rxiv__2022__11__16__516705-40-6-11?v=Addgene+inc
Average 92 stars, based on 1 article reviews
pcdna myc nlrp3 r260w - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

91
Addgene inc ptre2 bla crilp
Ptre2 Bla Crilp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pmc07659717-217-0-17?v=Addgene+inc
Average 91 stars, based on 1 article reviews
ptre2 bla crilp - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
Addgene inc gcamp3 plasmid
Gcamp3 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm34217831-64-5-12?v=Addgene+inc
Average 93 stars, based on 1 article reviews
gcamp3 plasmid - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
GenScript corporation pcdna3.1(+)-c-ha-asc
Pcdna3.1(+) C Ha Asc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm38583156-224-9-10?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
pcdna3.1(+)-c-ha-asc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Addgene inc christian stehlik
Christian Stehlik, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm40835597-168-7-9?v=Addgene+inc
Average 93 stars, based on 1 article reviews
christian stehlik - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

91
Addgene inc pcellfree g03 il1b
Pcellfree G03 Il1b, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pmc07226495-208-82-89?v=Addgene+inc
Average 91 stars, based on 1 article reviews
pcellfree g03 il1b - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
Addgene inc apex2 nlrp3 flag
Apex2 Nlrp3 Flag, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm38669140-212-38-47?v=Addgene+inc
Average 93 stars, based on 1 article reviews
apex2 nlrp3 flag - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

92
Addgene inc pci caspase1
Pci Caspase1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pmc07226495-208-46-52?v=Addgene+inc
Average 92 stars, based on 1 article reviews
pci caspase1 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

93
Addgene inc pcdna3 ha h ripk3
(A) Wild-type (WT) and Nlrc5−/− bone marrow-derived macrophages (BMDMs) were either left unstimulated (0 h) or treated with heme plus Pam3CSK4 (Pam3) for 36 h and stained for NLRC5, and counter-stained with DAPI to visualize nuclei. A broader, enlarged field of view for WT BMDMs at the 36 h timepoint is shown. (B) Western blot analysis of NLRC5 in WT BMDMs stimulated with heme plus Pam3 for the indicated times. For loading control, β-actin is shown. (C) WT and Nlrc5−/− BMDMs were either unstimulated (0 h) or treated with heme plus Pam3 for 36 h and stained for NLRC5, ASC, caspase-8 (CASP8), and <t>RIPK3,</t> and counter-stained with DAPI to visualize nuclei. Representative images of cells containing co-localized NLRC5, ASC, CASP8, and RIPK3 are shown. The magnified view of the boxed area (merged) is shown on the right (enlarged). (D) Quantification showing the percentage of cells with NLRC5+ASC+ CASP8+ RIPK3+ specks out of the total population of cells with ASC+ specks in WT and Nlrc5−/− BMDMs at 36 h post-stimulation with heme plus Pam3. Each data point indicates a single field of view (average n = 103 cells per field). (E) Immunoblot analysis (IB) of ASC, NLRC5, NLRP3, CASP8, and RIPK3 following immunoprecipitation (IP) with IgG control or anti-ASC antibodies in WT, Nlrp12−/−, Pycard−/−, and Nlrc5−/− BMDMs after treatment with heme plus Pam3 (H+P) for 28 h. Scale bars = 10 μm (A), 5 μm (C, merge column), and 1 μm (C, enlarged column). Nlrc5−/− BMDMs (ref. 56) (A, C–E) were used for stimulation. Three or more independent experiments were performed, and the data shown are from a single experiment that is representative. Mean ± SEM are shown (D). Statistical analyses were performed using the unpaired t test (D). ****P < 0.0001. See also Figure S5.
Pcdna3 Ha H Ripk3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pmc11283362-967-39-42?v=Addgene+inc
Average 93 stars, based on 1 article reviews
pcdna3 ha h ripk3 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

96
Addgene inc backbone 73955 n a lenticrispr v2
(A) Wild-type (WT) and Nlrc5−/− bone marrow-derived macrophages (BMDMs) were either left unstimulated (0 h) or treated with heme plus Pam3CSK4 (Pam3) for 36 h and stained for NLRC5, and counter-stained with DAPI to visualize nuclei. A broader, enlarged field of view for WT BMDMs at the 36 h timepoint is shown. (B) Western blot analysis of NLRC5 in WT BMDMs stimulated with heme plus Pam3 for the indicated times. For loading control, β-actin is shown. (C) WT and Nlrc5−/− BMDMs were either unstimulated (0 h) or treated with heme plus Pam3 for 36 h and stained for NLRC5, ASC, caspase-8 (CASP8), and <t>RIPK3,</t> and counter-stained with DAPI to visualize nuclei. Representative images of cells containing co-localized NLRC5, ASC, CASP8, and RIPK3 are shown. The magnified view of the boxed area (merged) is shown on the right (enlarged). (D) Quantification showing the percentage of cells with NLRC5+ASC+ CASP8+ RIPK3+ specks out of the total population of cells with ASC+ specks in WT and Nlrc5−/− BMDMs at 36 h post-stimulation with heme plus Pam3. Each data point indicates a single field of view (average n = 103 cells per field). (E) Immunoblot analysis (IB) of ASC, NLRC5, NLRP3, CASP8, and RIPK3 following immunoprecipitation (IP) with IgG control or anti-ASC antibodies in WT, Nlrp12−/−, Pycard−/−, and Nlrc5−/− BMDMs after treatment with heme plus Pam3 (H+P) for 28 h. Scale bars = 10 μm (A), 5 μm (C, merge column), and 1 μm (C, enlarged column). Nlrc5−/− BMDMs (ref. 56) (A, C–E) were used for stimulation. Three or more independent experiments were performed, and the data shown are from a single experiment that is representative. Mean ± SEM are shown (D). Statistical analyses were performed using the unpaired t test (D). ****P < 0.0001. See also Figure S5.
Backbone 73955 N A Lenticrispr V2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vectors+nlrp3+expression+vectors+pegfp+c2+nlrp3/pm38669140-212-106-111?v=Addgene+inc
Average 96 stars, based on 1 article reviews
backbone 73955 n a lenticrispr v2 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

Image Search Results


(A) Wild-type (WT) and Nlrc5−/− bone marrow-derived macrophages (BMDMs) were either left unstimulated (0 h) or treated with heme plus Pam3CSK4 (Pam3) for 36 h and stained for NLRC5, and counter-stained with DAPI to visualize nuclei. A broader, enlarged field of view for WT BMDMs at the 36 h timepoint is shown. (B) Western blot analysis of NLRC5 in WT BMDMs stimulated with heme plus Pam3 for the indicated times. For loading control, β-actin is shown. (C) WT and Nlrc5−/− BMDMs were either unstimulated (0 h) or treated with heme plus Pam3 for 36 h and stained for NLRC5, ASC, caspase-8 (CASP8), and RIPK3, and counter-stained with DAPI to visualize nuclei. Representative images of cells containing co-localized NLRC5, ASC, CASP8, and RIPK3 are shown. The magnified view of the boxed area (merged) is shown on the right (enlarged). (D) Quantification showing the percentage of cells with NLRC5+ASC+ CASP8+ RIPK3+ specks out of the total population of cells with ASC+ specks in WT and Nlrc5−/− BMDMs at 36 h post-stimulation with heme plus Pam3. Each data point indicates a single field of view (average n = 103 cells per field). (E) Immunoblot analysis (IB) of ASC, NLRC5, NLRP3, CASP8, and RIPK3 following immunoprecipitation (IP) with IgG control or anti-ASC antibodies in WT, Nlrp12−/−, Pycard−/−, and Nlrc5−/− BMDMs after treatment with heme plus Pam3 (H+P) for 28 h. Scale bars = 10 μm (A), 5 μm (C, merge column), and 1 μm (C, enlarged column). Nlrc5−/− BMDMs (ref. 56) (A, C–E) were used for stimulation. Three or more independent experiments were performed, and the data shown are from a single experiment that is representative. Mean ± SEM are shown (D). Statistical analyses were performed using the unpaired t test (D). ****P < 0.0001. See also Figure S5.

Journal: Cell

Article Title: NLRC5 senses NAD + depletion to form a PANoptosome driving PANoptosis and inflammation

doi: 10.1016/j.cell.2024.05.034

Figure Lengend Snippet: (A) Wild-type (WT) and Nlrc5−/− bone marrow-derived macrophages (BMDMs) were either left unstimulated (0 h) or treated with heme plus Pam3CSK4 (Pam3) for 36 h and stained for NLRC5, and counter-stained with DAPI to visualize nuclei. A broader, enlarged field of view for WT BMDMs at the 36 h timepoint is shown. (B) Western blot analysis of NLRC5 in WT BMDMs stimulated with heme plus Pam3 for the indicated times. For loading control, β-actin is shown. (C) WT and Nlrc5−/− BMDMs were either unstimulated (0 h) or treated with heme plus Pam3 for 36 h and stained for NLRC5, ASC, caspase-8 (CASP8), and RIPK3, and counter-stained with DAPI to visualize nuclei. Representative images of cells containing co-localized NLRC5, ASC, CASP8, and RIPK3 are shown. The magnified view of the boxed area (merged) is shown on the right (enlarged). (D) Quantification showing the percentage of cells with NLRC5+ASC+ CASP8+ RIPK3+ specks out of the total population of cells with ASC+ specks in WT and Nlrc5−/− BMDMs at 36 h post-stimulation with heme plus Pam3. Each data point indicates a single field of view (average n = 103 cells per field). (E) Immunoblot analysis (IB) of ASC, NLRC5, NLRP3, CASP8, and RIPK3 following immunoprecipitation (IP) with IgG control or anti-ASC antibodies in WT, Nlrp12−/−, Pycard−/−, and Nlrc5−/− BMDMs after treatment with heme plus Pam3 (H+P) for 28 h. Scale bars = 10 μm (A), 5 μm (C, merge column), and 1 μm (C, enlarged column). Nlrc5−/− BMDMs (ref. 56) (A, C–E) were used for stimulation. Three or more independent experiments were performed, and the data shown are from a single experiment that is representative. Mean ± SEM are shown (D). Statistical analyses were performed using the unpaired t test (D). ****P < 0.0001. See also Figure S5.

Article Snippet: For immunoprecipitation in the overexpression system, HEK293T cells (CRL-3216, ATCC) were seeded into six-well plates and transfected with a combined total of 5 ug of the following plasmids (1:1:1:1:1, molar ratio): pcDNA3-Myc-h ASC (#73952, Addgene), pcDNA3-h CASP8 (#11817, Addgene), pcDNA3-HA-h RIPK3 (#78804, Addgene), pcDNA3-Myc-h NLRC5 (#37509, Addgene), and pcDNA3-h NLRP12 -FLAG (Human NLRP12 PCR product amplified using cDNA and cloned in pcDNA TM 3.1 (+) Mammalian Expression Vector (#V790-20, Thermo Fisher Scientific), with or without an equimolar ratio of pEGFP-C2-h NLRP3 (#73955, Addgene), and incubated for 24–36 h. Immunoprecipitation was performed as previously described 12 , 102 with minor modifications.

Techniques: Derivative Assay, Staining, Western Blot, Control, Immunoprecipitation

Key Resources Table

Journal: Cell

Article Title: NLRC5 senses NAD + depletion to form a PANoptosome driving PANoptosis and inflammation

doi: 10.1016/j.cell.2024.05.034

Figure Lengend Snippet: Key Resources Table

Article Snippet: For immunoprecipitation in the overexpression system, HEK293T cells (CRL-3216, ATCC) were seeded into six-well plates and transfected with a combined total of 5 ug of the following plasmids (1:1:1:1:1, molar ratio): pcDNA3-Myc-h ASC (#73952, Addgene), pcDNA3-h CASP8 (#11817, Addgene), pcDNA3-HA-h RIPK3 (#78804, Addgene), pcDNA3-Myc-h NLRC5 (#37509, Addgene), and pcDNA3-h NLRP12 -FLAG (Human NLRP12 PCR product amplified using cDNA and cloned in pcDNA TM 3.1 (+) Mammalian Expression Vector (#V790-20, Thermo Fisher Scientific), with or without an equimolar ratio of pEGFP-C2-h NLRP3 (#73955, Addgene), and incubated for 24–36 h. Immunoprecipitation was performed as previously described 12 , 102 with minor modifications.

Techniques: Control, Virus, Recombinant, In Vitro, In Vivo, Protease Inhibitor, Western Blot, Iron Assay, AST Assay, Magnetic Beads, Enzyme-linked Immunosorbent Assay, Isolation, Transfection, Antibody Labeling, Gene Expression, Software